{"data":{"id":"us/21-cfr-522.2615","jurisdiction":"us","citation":"21 CFR 522.2615","heading":"Tripelennamine.","body":"(a) Specifications. Each milliliter of solution contains 20 milligrams (mg) of tripelennamine hydrochloride.\n(b) Sponsors. See Nos. 016592 and 051031 in § 510.600(c) of this chapter.\n(c) Related tolerances. See § 556.741 of this chapter.\n(d) Conditions of use—(1) Dogs and cats—(i) Amount. Administer 0.5 mg per pound of body weight by intramuscular injection.\n(ii) Indications for use. For use in treating conditions in which antihistaminic therapy may be expected to lead to alleviation of some signs of disease.\n(iii) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.\n(2) Horses—(i) Amount. Administer 0.5 mg per pound of body weight by intramuscular injection.\n(ii) Indications for use. For use in treating conditions in which antihistaminic therapy may be expected to lead to alleviation of some signs of disease.\n(iii) Limitations. Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.\n(3) Cattle—(i) Amount. Administer 0.5 mg per pound of body weight by intravenous or intramuscular injection.\n(ii) Indications for use. For use in treating conditions in which antihistaminic therapy may be expected to lead to alleviation of some signs of disease.\n(iii) Limitations. Milk taken during treatment and for 24 hours after the last treatment must not be used for human consumption. Cattle must not be slaughtered for human consumption within 4 days following the last treatment with this drug product. Not for use in beef calves less than 2 months of age, dairy calves, and veal calves. A withdrawal period has not been established for this product in pre-ruminating calves. Federal law restricts this drug to use by or on the order of a licensed veterinarian.","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER E—ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS","PART 522—IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"19d7a9f210cd64cbcea8128bb55bd76825d6c6bbec89d990b234b8791990988f","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-522.2610","next":"us/21-cfr-522.2630"},"notice":"GroundRules: Original legal text. Not legal advice."}